The DOI matches its Crossref record; 353 of the 353 references it cites were found in a registry or an index.
Monoamine transporters and psychostimulant addiction
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–353 of 353
The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats
Self, D. W., & Stein, L. (1992) · Brain Research · doi:10.1016/0006-8993(92)90155-3 · Cited by 130
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.5.658 · Cited by 129
Cocaine use increases [3HWIN 35428 binding sites in human striatum
Little, K. Y., Kirkman, J. A., Carroll, F. I., Clark, T. B., & Duncan, G. E. (1993) · Brain Research · doi:10.1016/0006-8993(93)90932-d · Cited by 129
Gonzalez, G. M., Sevarino, K. A., Sofuoglu, M., Poling, J., Oliveto, A. H., Gonsai, K., George, T. P., & Kosten, T. R. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00544.x · Cited by 128
The Functional Impact of SLC6 Transporter Genetic Variation
Hahn, M. K., & Blakely, R. (2006) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105242 · Cited by 128
Volkow, N. D., Wang, G.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Dewey, S. L., Hitzemann, R., Gifford, A. N., & Pappas, N. R. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37918-2 · Cited by 125
Sitte, H. H., Farhan, H., & Javitch, J. A. (2004) · Molecular Interventions · doi:10.1124/mi.4.1.38 · Cited by 124
Drouin, C., Blanc, G., Villégier, A., Glowinski, J., & Tassin, J. (2001) · Synapse · doi:10.1002/syn.10023 · Cited by 124
Lategan, A. J., Marien, M. R., & Colpaert, F. C. (1990) · Brain Research · doi:10.1016/0006-8993(90)91646-x · Cited by 123
Chi, L., & Reith, M. E. A. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.055095 · Cited by 123
Kushner, S. A., Dewey, S. L., & Kornetsky, C. H. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34966-3 · Cited by 123
Mazei‐Robison, M. S., Couch, R. S., Shelton, R. C., Stein, M. A., & Blakely, R. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.08.003 · Cited by 122
Negus, S. S., & Mello, N. K. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00339-3 · Cited by 121
Cornish, J. L., & Kalivas, P. W. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v20n03_05 · Cited by 119
Phorbol esters alter functions of the expressed dopamine transporter
Kitayama, S., Dohi, T., & Uhl, G. R. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90180-5 · Cited by 118
Glutamate Transmission and Addiction to Cocaine
Kalivas, P. W., McFarland, K., Bowers, M. S., Szumlinski, K. K., Xi, Z., & Baker, D. L. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.009 · Cited by 118
Jacob, G., Shannon, J. R., Costa, F., Furlan, R., Biaggioni, I., Mosqueda-Garcia, R., Robertson, R. M., & Robertson, D. (1999) · Circulation · doi:10.1161/01.cir.99.13.1706 · Cited by 117
Role of monoamine transporters in mediating psychostimulant effects
Riddle, E. L., Fleckenstein, A. E., & Hanson, G. R. (2005) · The AAPS Journal · doi:10.1208/aapsj070481 · Cited by 117
Porrino, L. J., Ritz, M. C., Goodman, N. L., Sharpe, L. G., Kuhar, M. J., & Goldberg, S. R. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90418-9 · Cited by 117
Carlezon, W. A., & Konradi, C. L. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.021 · Cited by 117
Risperidone for the Treatment of Cocaine Dependence: Randomized, Double-Blind Trial
Grabowski, J. G., Rhoades, H. M., Silverman, P. B., Schmitz, J. M., Stotts, A. L., Creson, D., & Bailey, R. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200006000-00003 · Cited by 116
Rationale for maintenance pharmacotherapy of opiate dependence.
Kreek, M. J. (1992) · PubMed · Cited by 115
Howell, L. L., & Wilcox, K. M. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29344-7 · Cited by 115
Self-citationSchweitzer, J. B., Lee, D. O., Hanford, R. B., Tagamets, M. A., Hoffman, J. M., Grafton, S. T., & Kilts, C. D. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300110 · Cited by 114
Kushner, S. A., Dewey, S. L., & Kornetsky, C. H. (1999) · PubMed · Cited by 114
Baumann, M. H., AYESTAS, M. A., Dersch, C. M., Brockington, A., Rice, K. C., & Rothman, R. B. (2000) · Synapse · Cited by 113
The reinforcing effects of dopamine D1 receptor agonists in rhesus monkeys.
Weed, M., & Woolverton, W. L. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12193-9 · Cited by 113
Nirenberg, M. J., Chan, J., Vaughan, R. A., Uhl, G. R., Kuhar, M. J., & Pickel, V. M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04037.1997 · Cited by 112
The vesiicular monoamine transporter: from chromaffin granule to brain
Henry, J., Sagné, C., Bedet, C., & Gasnier, B. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(97)00092-2 · Cited by 109
Goeders, N. E., & Kuhar, M. J. (1987) · PubMed · Cited by 108
Just, H., Sitte, H. H., Schmid, J. A., Freissmuth, M., & Kudlacek, O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306092200 · Cited by 108
Mascio, M. D., Giovanni, G. D., Matteo, V. D., Prisco, S., & Esposito, E. (1998) · Brain Research Bulletin · doi:10.1016/s0361-9230(98)00054-9 · Cited by 107
Fluoxetine Alters the Effects of Intravenous Cocaine in Humans
WALSH, S. L., Preston, K. L., Sullivan, J. T., FROMME, R., & Bigelow, G. E. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199412000-00005 · Cited by 107
Hahn, M. K., Robertson, D., & Blakely, R. D. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-11-04470.2003 · Cited by 107
Macey, D. J., Smith, H. R., Nader, M. A., & Porrino, L. J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00012.2003 · Cited by 106
A controlled trial of fluoxetine in crack cocaine dependence
Batki, S. L., Washburn, A. M., Delucchi, K., & Jones, R. T. (1996) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(96)01233-1 · Cited by 106
Serotonergic Attenuation of the Reinforcing and Neurochemical Effects of Cocaine in Squirrel Monkeys
Czoty, P. W., Ginsburg, B. C., & Howell, L. L. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.831 · Cited by 105
Self-citationNoradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys.
Spealman, R. D. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12081-8 · Cited by 104
Grünhage, F., Schulze, T. G., Müller, D., Lanczik, M., Franzek, E., Albus, M., Borrmann-Hassenbach, M., Knapp, M., Cichon, S., Maier, W., et al. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000711 · Cited by 104
Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals
Weinshenker, D., Miller, N. S., Blizinsky, K. D., Laughlin, M. L., & Palmiter, R. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212519999 · Cited by 103
Ginovart, N., Farde, L., Halldin, C., & Swahn, C. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199704)25:4<393::aid-syn11>3.0.co;2-w · Cited by 103
Autoradiographic localization of ?-aminobutyric acidA receptors within the ventral tegmental area
Churchill, L., Dilts, R. P., & Kalivas, P. W. (1992) · Neurochemical Research · doi:10.1007/bf00966870 · Cited by 103
Cellular and subcellular localization of the dopamine transporter in rat cortex
Sesack, S. R., Hawrylak, V. A., Guido, M. A., & Levey, A. I. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60720-6 · Cited by 101
Beurrier, C., & Malenka, R. C. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-14-05817.2002 · Cited by 101
Amygdala dopamine levels are markedly elevated after self- but not passive-administration of cocaine
Wilson, J. M., Nobrega, J., Corrigall, W. A., Coen, K., Shannak, K. S., & Kish, S. J. (1994) · Brain Research · doi:10.1016/0006-8993(94)90508-8 · Cited by 101
Effects of monoamine reuptake inhibitors on cocaine self-administration in rats
Tella, S. R. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)00438-o · Cited by 99
Noradrenergic Dysregulation During Discontinuation of Cocaine Use in Addicts
McDougle, C. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950090045007 · Cited by 98
Morgan, A. E., & Dewey, S. L. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199801)28:1<60::aid-syn7>3.0.co;2-a · Cited by 98
Acute and Chronic Dopamine Dynamics in a Nonhuman Primate Model of Recreational Cocaine Use
Bradberry, C. W. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-18-07109.2000 · Cited by 98
Howell, L. L., & Byrd, L. D. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20249-x · Cited by 96
Self-citationEffects of repeated oral methamphetamine administration in humans
Comer, S. D., Hart, C. L., Ward, A. S., Haney, M., Foltin, R. W., & Fischman, M. W. (2001) · Psychopharmacology · doi:10.1007/s002130100727 · Cited by 91
Impact of psychostimulants on vesicular monoamine transporter function
Fleckenstein, A. E., & Hanson, G. R. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.077 · Cited by 91
Glutamatergic Agents for Cocaine Dependence
Dackis, C. A., & O’Brien, C. P. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.021 · Cited by 89
Sensitization to the reinforcing effects of cocaine following binge-abstinent self-administration
Morgan, D., & Roberts, D. C. S. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.11.004 · Cited by 89
Tella, S. R., Ladenheim, B., Andrews, A. M., Goldberg, S. R., & Cadet, J. L. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-23-07416.1996 · Cited by 88
Nirenberg, M. J., Chan, J., Vaughan, R. A., Uhl, G. R., Kuhar, M. J., & Pickel, V. M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05255.1997 · Cited by 88
Woolverton, W. L. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90618-6 · Cited by 87
Loss of Serotonin Transporter Protein after MDMA and Other Ring-Substituted Amphetamines
Xie, T., Tong, L., McLane, M. W., Hatzidimitriou, G., Yuan, J., McCann, U. D., & Ricaurte, G. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301031 · Cited by 86
Baumann, M. H., & Rothman, R. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00123-1 · Cited by 86
Behavioral effects of novel cocaine analogs: a comparison with in vivo receptor binding potency.
Cline, E. J., Scheffel, U., Boja, J. W., Carroll, F. I., Katz, J. L., & Kuhar, M. J. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11425-0 · Cited by 86
Dwoskin, L. P., Peris, J., Yasuda, R. P., Philpott, K., & Zahniser, N. R. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90634-0 · Cited by 85
Donnan, G. A., Kaczmarczyk, S. J., Paxinos, G., Chilco, P. J., Kalnins, R. M., Woodhouse, D. G., & Mendelsohn, F. A. O. (1991) · The Journal of Comparative Neurology · doi:10.1002/cne.903040307 · Cited by 85
Rothman, R. B., Blough, B. E., Woolverton, W. L., Anderson, K. G., Negus, S. S., Mello, N. K., Roth, B. L., & Baumann, M. H. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.082503 · Cited by 85
Cocaine abuse : behavior, pharmacology, and clinical applications
Higgins, S. T., & Katz, J. L. (1998) · Cited by 84
Liprando, L. A., Miner, L. H., Blakely, R., Lewis, D. A., & Sesack, S. R. (2004) · Synapse · doi:10.1002/syn.20023 · Cited by 84
A pilot trial of olanzapine for the treatment of cocaine dependence
Kampman, K. M., Pettinati, H. M., Lynch, K. G., Sparkman, T., & O’Brien, C. P. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00009-7 · Cited by 81
Kleven, M. S., & Woolverton, W. L. (1993) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(93)90067-z · Cited by 79
Glowa, J. R., Wojnicki, F. H. E., Matecka, D., Bacher, J. D., Mansbach, R. S., Balster, R. L., & Rice, K. C. (1995) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.3.3.219 · Cited by 78
Pilotte, N. S., Sharpe, L. G., & Kuhar, M. J. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38838-5 · Cited by 78
Human Response to Repeated Low-Dose d-Amphetamine: Evidence for Behavioral Enhancement and Tolerance
Strakowski, S. M. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00253-6 · Cited by 75
Effects of cocaine alone and in combination with mazindol in human cocaine abusers.
Preston, K. L., Sullivan, J. T., Berger, P. A., & Bigelow, G. E. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39434-6 · Cited by 75
Modafinil evokes striatal [3H]dopamine release and alters the subjective properties of stimulants
Dopheide, M. M., Morgan, R. E., Rodvelt, K. R., Schachtman, T. R., & Miller, D. K. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.03.044 · Cited by 74
Effect of cocaine self-administration on striatal dopamine D1 receptors in rhesus monkeys
Moore, R. J., Vinsant, S. L., Nader, M. A., Porrino, L. J., & Friedman, D. P. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199801)28:1<1::aid-syn1>3.0.co;2-g · Cited by 74
The Noradrenaline Transporter of the Neuronal Plasma Membranea
Bönisch, H., & Brüss, M. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb17269.x · Cited by 74
Howell, L. L., Carroll, F. I., Votaw, J. R., Goodman, M. M., & Kimmel, H. L. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.108324 · Cited by 73
Self-citationGamma-vinyl GABA attenuates cocaine-induced lowering of brain stimulation reward thresholds
Kushner, S. A., Dewey, S. L., & Kornetsky, C. H. (1997) · Psychopharmacology · doi:10.1007/s002130050418 · Cited by 71
Dopamine D1 and D2 Receptors Influence Dopamine Transporter Synthesis and Degradation in the Rat
Kimmel, H. L., Joyce, A. R., Carroll, F. I., & Kuhar, M. J. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29360-5 · Cited by 70
Self-citationHerman, B. H., Frankenheim, J., Litten, R. Z., Sheridan, P. H., Weight, F. F., & Zukin, S. R. (2002) · Humana Press eBooks · doi:10.1385/1592593062 · Cited by 69
Kocabas, A., Rudnick, G., & Kilic, F. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01793.x · Cited by 67
George, T. P., Verrico, C. D., Picciotto, M. R., & Roth, R. H. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38869-x · Cited by 66
Methylphenidate and Dextroamphetamine Abuse in Substance‐Abusing Adolescents
Williams, R. J., Goodale, L. A., Shay‐Fiddler, M. A., Gloster, S. P., & Chang, S. Y. (2004) · American Journal on Addictions · doi:10.1080/10550490490483053 · Cited by 63
Howell, L. L., Hoffman, J. M., Votaw, J. R., Landrum, A. M., Wilcox, K. M., & Lindsey, K. P. (2001) · Psychopharmacology · doi:10.1007/s002130100911 · Cited by 62
Self-citationDeurwaerdère, P. D., L'hirondel, M., Bonhomme, N., Lucas, G., Chéramy, A., & Spampinato, U. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010195.x · Cited by 61
Strakowski, S. M., Sax, K. W., Setters, M. J., Stanton, S. P., & Keck, P. E. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00052-8 · Cited by 61
Subjective and behavioral effects of repeated d-amphetamine in humans
Wachtel, S. R., & de Wit, H. (1999) · Behavioural Pharmacology · doi:10.1097/00008877-199905000-00004 · Cited by 61
Bauman, P. A., & Blakely, R. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00232-1 · Cited by 60
Effects of Cocaine and MDMA Self-Administration on Serotonin Transporter Availability in Monkeys
Banks, M. L., Czoty, P. W., Gage, H. D., Bounds, M. C., Garg, P., Garg, S., & Nader, M. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301420 · Cited by 60
Relationships among dopamine transporter affinities and cocaine-like discriminative-stimulus effects
Katz, J. L., Izenwasser, S., & Terry, P. (2000) · Psychopharmacology · doi:10.1007/s002130050029 · Cited by 59
Wilcox, K. M., Lindsey, K. P., Votaw, J. R., Goodman, M. M., Martarello, L., Carroll, F. I., & Howell, L. (2001) · Synapse · doi:10.1002/syn.10018 · Cited by 59
Self-citationVillemagne, V. L., Rothman, R. B., Yokoi, F., Rice, K. C., Matecka, D., Dannals, R. F., & Wong, D. F. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199904)32:1<44::aid-syn6>3.0.co;2-9 · Cited by 57
Mazindol treatment for cocaine dependence
Stine, S. M., Krystal, J. H., Kosten, T. R., & Charney, D. S. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01174-4 · Cited by 57
Targeting Exocytosis: Ins and Outs of the Modulation of Quantal Dopamine Release
Westerink, R. H. S. (2006) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152706784111597 · Cited by 57
Modulation of intravenous cocaine effects by chronic oral cocaine in humans
WALSH, S. L., Haberny, K. A., & Bigelow, G. E. (2000) · Psychopharmacology · doi:10.1007/s002130000439 · Cited by 56
Dominant Negative Isoform of Rat Norepinephrine Transporter Produced by Alternative RNA Splicing
Kitayama, S., Ikeda, T., Mitsuhata, C., Sato, T., Morita, K., & Dohi, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10731 · Cited by 56
Antagonism of behavioral effects of cocaine by selective dopamine receptor blockers
Spealman, R. D. (1990) · Psychopharmacology · doi:10.1007/bf02253732 · Cited by 55
Nader, M. A., Grant, K. A., Davies, H. M. L., Mach, R. H., & Childers, S. R. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36440-7 · Cited by 55
GABA Modulation of Cocaine Self‐Administration
Roberts, D. C. S., & Brebner, K. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06680.x · Cited by 54
Effects of chronic cocaine administration on dopamine transporter mRNA and protein in the rat
Letchworth, S. R., Daunais, J. B., Hedgecock, A. A., & Porrino, L. J. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01384-4 · Cited by 54
Nader, M. A., Grant, K. A., Davies, H. M. L., et al. (1997) · PubMed · Cited by 54
Vezina, P., Pierre, P. J., & Lorrain, D. S. (1999) · Psychopharmacology · doi:10.1007/s002130051152 · Cited by 53
Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT
Darvesh, A. S., & Gudelsky, G. A. (2005) · Brain Research · doi:10.1016/j.brainres.2005.07.009 · Cited by 53
Kleven, M. S., Anthony, E., Goldberg, L. I., & Woolverton, W. L. (1988) · Psychopharmacology · doi:10.1007/bf00181961 · Cited by 53
Meta-analysis of desipramine as an adjunct in the treatment of cocaine addiction.
LEVIN, F. R., & Lehman, A. F. (1991) · PubMed · Cited by 51
Mazei‐Robison, M. S., & Blakely, R. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.08.012 · Cited by 51
Monique Ernst, D., Zametkin, A. J., Matochik, J. A., Liebenauer, L. L., FITZGERALD, G. A., & Cohen, R. M. (1994) · PubMed · Cited by 49
Plasticity in serotonin uptake in primary neuronal cultures of serotonin transporter knockout mice
Pan, Y., Gembom, E., Peng, W., Lesch, K., Mößner, R., & Simantov, R. (2001) · Developmental Brain Research · doi:10.1016/s0165-3806(00)00145-0 · Cited by 48
Noradrenergic Mechanisms in Cocaine-Induced Reinstatement of Drug Seeking in Squirrel Monkeys
Platt, D. M., Rowlett, J. K., & Spealman, R. D. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121806 · Cited by 48
Bergman, J., & Spealman, R. D. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22640-4 · Cited by 48
Pharmacological interactions between serotonin and dopamine on behavior in the squirrel monkey
Howell, L. L., Czoty, P. W., & Byrd, L. D. (1997) · Psychopharmacology · doi:10.1007/s002130050263 · Cited by 46
Self-citationEffect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans
Evans, S. M., WALSH, S. L., LEVIN, F. R., Foltin, R. W., Fischman, M. W., & Bigelow, G. E. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00129-6 · Cited by 45
Kleven, M. S., & Woolverton, W. L. (1990) · Psychopharmacology · doi:10.1007/bf02244128 · Cited by 44
Phelix, C. F., & Broderick, P. A. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(94)00253-3 · Cited by 43
Effects of modafinil-induced wakefulness on glutamine synthetase regulation in the rat brain
Touret, M., Sallanon, M. M., Fages, C., Roudier, V., Didier‐Bazès, M., Roussel, B., Tardy, M., & Jouvet, M. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90082-5 · Cited by 43
The role of co-transported sodium in the effect of indirectly acting sympathomimetic amines
B�nisch, H. (1986) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00511403 · Cited by 42
Evaluation of the discriminative stimulus and reinforcing effects of sertraline in rhesus monkeys
Vanover, K. E., Nader, M. A., & Woolverton, W. L. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90228-8 · Cited by 41
Howell, L. L., Czoty, P. W., Kuhar, M. J., & Carroll, F. I. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35321-2 · Cited by 40
Self-citationPlatt, D. M., Rowlett, J. K., & Spealman, R. D. (2001) · Psychopharmacology · doi:10.1007/s002130100779 · Cited by 40
Role of D1 and D2 dopamine receptors in the behavioral effects of cocaine
Spealman, R. D., Bergman, J., Madras, B. K., Kamien, J. B., & Melia, K. F. (1992) · Neurochemistry International · doi:10.1016/0197-0186(92)90228-j · Cited by 40
Claye, L. H., Akunne, H. C., Davis, M. D., DeMattos, S., & Soliman, K. F. A. (1995) · Molecular Neurobiology · doi:10.1007/bf02740684 · Cited by 40
Effects of bromocriptine pretreatment on subjective and physiological responses to IV cocaine
Kumor, K. M., Sherer, M. A., & Jaffe, J. H. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90478-4 · Cited by 40
Richards, M., Iijima, Y., Kondo, H., Shizuno, T., Hori, H., Arima, K., Saitoh, O., & Kunugi, H. (2006) · Behavioral and Brain Functions · doi:10.1186/1744-9081-2-39 · Cited by 40
The role of serotonin in the actions of psychostimulants: molecular and pharmacological analyses
Cunningham, K. A., Bradberry, C. W., Chang, A. S., & Reith, M. E. A. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00077-0 · Cited by 39
Boulay, D., Duterte‐Boucher, D., Leroux‐Nicollet, I., Naudon, L., & Costentin, J. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20139-2 · Cited by 38
Kimmel, H. L., Carroll, F. I., & Kuhar, M. J. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00160-4 · Cited by 37
Self-citationInhibition of cocaine self-administration by fluoxetine or d-fenfluramine combined with phentermine
Glatz, A. C., Ehrlich, M. E., Bae, R. S., Clarke, M. J., Quinlan, P. A., Brown, E. C., Rada, P. V., & Hoebel, B. G. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00657-8 · Cited by 37
(2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(02)00338-4 · Cited by 37
Mutschler, N. H., & Bergman, J. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0976-z · Cited by 36
Neurotransmitter transport: Models in flux
Kavanaugh, M. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.12737 · Cited by 36
Mutation in the vesicular monoamine gene, SLC18A1, associated with schizophrenia
Bly, M. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.04.011 · Cited by 36
Cocaine doses equivalent to those abused by humans occupy most of the dopamine transporters
Volkow, N. D., Gatley, S. J., Fowler, J. S., Logan, J., Fischman, M. W., Gifford, A. N., Pappas, N., King, P. T., Vitkun, S. A., Ding, Y., et al. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199612)24:4<399::aid-syn7>3.0.co;2-8 · Cited by 35
Regulation of Rat Dopamine Transporter mRNA and Protein by Chronic Cocaine Administration
Letchworth, S. R., Sexton, T., Childers, S. R., Vrana, K. E., Vaughan, R. A., Davies, H. M. L., & Porrino, L. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.01982.x · Cited by 35
Effect of serotonergic agonists in the nucleus accumbens on d-amphetamine-stimulated locomotion
Layer, R. T., Uretsky, N. J., & Wallace, L. J. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90187-t · Cited by 34
Ricaurte, G. A., & McCann, U. D. (2001) · Neurotoxicity Research · doi:10.1007/bf03033232 · Cited by 34
Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers
Mash, D. C., Ouyang, Q., Qin, Y., & Pablo, J. P. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2004.09.013 · Cited by 32
Lin, Z., & Uhl, G. R. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500169 · Cited by 30
Distribution of [3H]Citalopram Binding Sites in the Nonhuman Primate Brain
Smith, H. R., Daunais, J. B., Nader, M. A., & Porrino, L. J. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09305.x · Cited by 30
Aberrant accumulation of serotonin in dopaminergic neurons
Mößner, R., Simantov, R., Marx, A., Lesch, K., & Seif, I. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.02.081 · Cited by 30
Human Genetics and Pharmacology of Neurotransmitter Transporters
Lin, Z., & Madras, B. K. (2006) · Handbook of experimental pharmacology · doi:10.1007/3-540-29784-7_16 · Cited by 29
Desipramine effects on cocaine self-administration by rhesus monkeys
Mello, N. K., Lukas, S. E., Bree, M. P., & Mendelson, J. H. (1990) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(90)90117-w · Cited by 29
Withdrawal from Repeated Cocaine Alters Dopamine Transporter Protein Turnover in the Rat Striatum
Kimmel, H. L., Carroll, F. I., & Kuhar, M. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.038018 · Cited by 27
Self-citationSerotonin transporter production and degradation rates: studies with RTI-76
Vicentic, A., Battaglia, G., Carroll, F. I., & Kuhar, M. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01761-8 · Cited by 26
Platt, D. M., Rodefer, J. S., Rowlett, J. K., & Spealman, R. D. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1347-0 · Cited by 26
Impact of Desipramine or Carbamazepine on Patient Retention in Outpatient Cocaine Treatment:
Campbell, J. L., Thomas, H. M., Gabrielli, W. F., Liskow, B. I., & Powell, B. J. (1995) · Journal of Addictive Diseases · doi:10.1300/j069v13n04_07 · Cited by 24
Vesicular Neurotransmitter Transporters*: Pharmacology, Biochemistry, and Molecular Analysis
Yelin, R., & Schuldiner, S. (2003) · Humana Press eBooks · doi:10.1385/1-59259-158-2:313 · Cited by 21
Effects of chronic cocaine treatment on rat brain: Long-term reduction in frontal cortical serotonin
Egan, M. F., Wing, L. L., Li, R., Kirch, D. G., & Wyatt, R. J. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90079-5 · Cited by 19
Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys
Ginsburg, B. C., Kimmel, H. L., Carroll, F. I., Goodman, M. M., & Howell, L. L. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.004 · Cited by 19
Self-citationStimulant sensitization in humans
Gorelick, D. A., & Rothman, R. B. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)80005-4 · Cited by 18
Open-label pilot study of bupropion plus bromocriptine for treatment of cocaine dependence
Montoya, I. D., Preston, K. L., Rothman, R. B., & Gorelick, D. A. (2002) · The American Journal of Drug and Alcohol Abuse · doi:10.1081/ada-120001288 · Cited by 16
Drugs for Cocaine Dependence: Not Easy
Krajewski, K. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110069011 · Cited by 15
Ravna, A. W. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970500402144 · Cited by 12
Tolerance and Sensitization to Cocaine
Woolverton, W. L., & Weiss, S. R. B. (1998) · Elsevier eBooks · doi:10.1016/b978-012347360-8/50007-0 · Cited by 11
Schlemmer, R. F., Young, J. E., & Davis, J. M. (1996) · Journal of Psychopharmacology · doi:10.1177/026988119601000110 · Cited by 8
Glutamate and the Self-Administration of Psychomotor-Stimulant Drugs
Vezina, P., & Suto, N. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-306-4_12 · Cited by 7
Cited by
Stimulant Abuse: Pharmacology, Cocaine, Methamphetamine, Treatment, Attempts at Pharmacotherapy
Ciccarone, D. (2011) · Primary Care: Clinics in Office Practice · doi:10.1016/j.pop.2010.11.004 · Cited by 200
A highly tunable dopaminergic oscillator generates ultradian rhythms of behavioral arousal
Blum, I. D., Zhu, L., Moquin, L., Kokoeva, M. V., Gratton, A., Giros, B., & Storch, K.-F. (2014) · eLife · doi:10.7554/elife.05105 · Cited by 168
Zhu, J., & Reith, M. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708786927877 · Cited by 140
dela Peña, I., Gevorkiana, R., & Shi, W.-X. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.07.044 · Cited by 116
Illicit dopamine transients: reconciling actions of abused drugs
Covey, D. P., Roitman, M. F., & Garris, P. A. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.02.002 · Cited by 90
Metadata
- Authors
- Howell, L. L., & Kimmel, H. L.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 75
- Issue
- 1
- Pages
- 196-217
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2107617181
- Cited by
- 255
- References
- 353
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.